Department of Cardiothoracic Surgery, Catharina Hospital, Eindhoven, the Netherlands.
Department of Cardiology, Catharina Hospital, Eindhoven, the Netherlands; Departments of Biomedical Technology, Eindhoven University of Technology, the Netherlands.
Int J Cardiol. 2024 Aug 15;409:132175. doi: 10.1016/j.ijcard.2024.132175. Epub 2024 May 14.
This study compared perioperative outcomes after off-pump revascularization through a thoracoscopic-assisted (non-robotic) minimally invasive approach (Endo-CAB) or sternotomy approach (OPCAB) for patients with single vessel left anterior descending (LAD) disease.
In this retrospective, propensity matched cohort study, 266 consecutive patients were included in the Endo-CAB group (n = 136) and OPCAB group (n = 130). After propensity score matching 116 Endo-CAB and 116 OPCAB patients were compared. 'Textbook outcome' was defined as the absence of 30-day mortality, re-exploration for bleeding, postoperative ischemia, cardiac tamponade, cerebrovascular events, wound infection, new-onset arrhythmias, pneumonia, placement of chest drains and prolonged hospital stay (> 7 days). Multivariable regression analysis was performed to identify independent predictors for textbook outcome.
Textbook outcome occurred significantly more frequent in the Endo-CAB group compared to the OPCAB group (81.9% vs. 59.5%, p < 0.001). Patients undergoing Endo-CAB surgery had shorter hospital admission (3.0 [3.0-4.0] vs. 5.0 [4.0-6.0] days, p < 0.001), less blood loss (225 [150-355] vs. 450 [350-600] mL, p < 0.001). Other perioperative outcomes were comparable for both groups. Regression analysis demonstrated that Endo-CAB approach was an independent positive predictor for textbook outcome (OR 3.02, 95% CI 1.61-5.66, p < 0.001).
Our study suggests that patients undergoing Endo-CAB surgery have improved perioperative outcome resulting in higher rates of textbook outcome for the treatment of single vessel CAD. This technique could be widely available since routine thoracoscopic instruments are used.
本研究比较了经胸腔镜辅助(非机器人)微创途径(Endo-CAB)或胸骨切开术途径(OPCAB)进行非体外循环冠状动脉旁路移植术(off-pump revascularization)治疗单支左前降支(LAD)疾病患者的围手术期结局。
在这项回顾性、倾向评分匹配的队列研究中,266 例连续患者被纳入 Endo-CAB 组(n=136)和 OPCAB 组(n=130)。在倾向评分匹配后,比较了 116 例 Endo-CAB 和 116 例 OPCAB 患者。“教科书结局”定义为 30 天内无死亡、再次出血探查、术后缺血、心脏压塞、脑血管事件、伤口感染、新发心律失常、肺炎、放置胸腔引流管和住院时间延长(>7 天)。进行多变量回归分析以确定教科书结局的独立预测因素。
Endo-CAB 组的教科书结局发生率明显高于 OPCAB 组(81.9%比 59.5%,p<0.001)。行 Endo-CAB 手术的患者住院时间更短(3.0[3.0-4.0]天比 5.0[4.0-6.0]天,p<0.001),失血量更少(225[150-355]毫升比 450[350-600]毫升,p<0.001)。两组的其他围手术期结局相当。回归分析表明,Endo-CAB 方法是教科书结局的独立正预测因素(OR 3.02,95%CI 1.61-5.66,p<0.001)。
我们的研究表明,接受 Endo-CAB 手术的患者围手术期结局改善,导致单支 CAD 治疗的教科书结局发生率更高。由于常规使用胸腔镜器械,因此该技术可能广泛应用。